Seeing Is Believing
CCCC is currently covered by 11 analysts with an average price target of $20.58. This is a potential upside of $12.53 (155.65%) from yesterday's end of day stock price of $8.05.
C4 Therapeutics 's activity chart (see below) currently has 16 price targets and 39 ratings on display. The stock rating distribution of CCCC is 42.86% BUY, 17.86% SELL and 39.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 37.77% with an average time for these price targets to be met of 45.64 days.
Highest price target for CCCC is $15, Lowest price target is $6, average price target is $20.58.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 26-Feb-2024. First documented stock forecast 27-Oct-2020.
Currently out of the existing stock ratings of CCCC, 12 are a BUY (42.86%), 5 are a SELL (17.86%), 11 are a HOLD (39.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
8
$-0.05 (-0.62%)
3
1 months 2 days ago
4/4 (100%)
$-1.51 (-15.88%)
39
Buy
13
$4.95 (61.49%)
12
1 months 5 days ago
4/7 (57.14%)
$4.01 (44.61%)
102
Hold
6
$-2.05 (-25.47%)
5
1 months 28 days ago
2/4 (50%)
$-0.33 (-5.21%)
7
Buy
7
$-1.05 (-13.04%)
17
4 months 26 days ago
1/4 (25%)
$5.6 (400.00%)
68
Buy
20
4 months 26 days ago
0/1 (0%)
$11.99 (149.69%)
What is CCCC (C4 Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?
Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?
Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?